TCI Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-138
Closed -$1.43K 789
2023
Q1
$1.43K Sell
138
-187
-58% -$2.26K ﹤0.01% 2045
2022
Q4
$3.84K Buy
325
+322
+10,733% +$4.98K ﹤0.01% 1699
2022
Q3
$0 Sell
3
-150
-98% -$4.17K ﹤0.01% 2322
2022
Q2
$5K Buy
153
+18
+13% +$615 ﹤0.01% 1463
2022
Q1
$5K Sell
135
-1
-0.7% -$44 ﹤0.01% 1521
2021
Q4
$6K Buy
136
+102
+300% +$4.61K ﹤0.01% 1517
2021
Q3
$2K Sell
34
-59
-63% -$3.57K ﹤0.01% 2107
2021
Q2
$6K Buy
93
+3
+3% +$193 ﹤0.01% 1300
2021
Q1
$8K Buy
90
+44
+96% +$4.51K ﹤0.01% 971
2020
Q4
$4K Hold
46
﹤0.01% 950
2020
Q3
$5K Hold
46
﹤0.01% 761
2020
Q2
$4K Hold
46
﹤0.01% 789
2020
Q1
$3K Buy
46
+12
+35% +$692 ﹤0.01% 849
2019
Q4
$2K Hold
34
﹤0.01% 1128
2019
Q3
$2K Hold
34
﹤0.01% 1063
2019
Q2
$2K Hold
34
﹤0.01% 998
2019
Q1
$2K Hold
34
﹤0.01% 1012
2018
Q4
$2K Hold
34
﹤0.01% 982
2018
Q3
$2K Hold
34
﹤0.01% 1021
2018
Q2
$2K Hold
34
﹤0.01% 1058
2018
Q1
$2K Hold
34
﹤0.01% 958
2017
Q4
$2K Hold
34
﹤0.01% 1011
2017
Q3
$1K Hold
34
﹤0.01% 1093
2017
Q2
$1K Buy
+34
New +$1.05K ﹤0.01% 1116
2016
Q3
Sell
-58
Closed -$2K 1367
2016
Q2
$2K Hold
58
﹤0.01% 923
2016
Q1
$2K Buy
+58
New +$2.05K ﹤0.01% 936

Other funds holding EBS

TCI Wealth Advisors's EBS Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Emergent Biosolutions (EBS) in Q2 2023, closing a stake of 138 shares — an estimated $1.43K sold.

TCI Wealth Advisors first reported a position in EBS in Q1 2016 and held it in 26 quarters. The position peaked at $8K in Q1 2021. 182 funds tracked by Wall St. Rank hold EBS as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Emergent Biosolutions position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 138 Emergent Biosolutions shares in Q2 2023, an estimated $1.43K.
  • TCI Wealth Advisors first reported a position in Emergent Biosolutions in Q1 2016 and held it in 26 quarters.
  • TCI Wealth Advisors's Emergent Biosolutions position peaked at $8K in Q1 2021.
  • 182 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.